Joel Isaacson & Co’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Joel Isaacson & Co’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4	Closed	-$8K	–	782
2015 Q2	$8K	Hold	4	–	–	﹤0.01%	623
2015 Q1	$11K	Hold	4	–	–	﹤0.01%	561
2014 Q4	$12K	Hold	4	–	–	﹤0.01%	492
2014 Q3	$13K	Hold	4	–	–	﹤0.01%	464
2014 Q2	$14K	Hold	4	–	–	﹤0.01%	448
2014 Q1	$15K	Hold	4	–	–	0.01%	443
2013 Q4	$14K	Hold	4	–	–	0.01%	408
2013 Q3	$15K	Hold	4	–	–	0.01%	384
2013 Q2	$37K	Buy	+4	New	+$44.3K	0.02%	263

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SGAM

Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Joel Isaacson & Co's FRTX Position: Q3 2015 in Review

Joel Isaacson & Co sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2015, closing a stake of 4 shares — an estimated $8K sold.

Joel Isaacson & Co first reported a position in FRTX in Q2 2013 and held it in 9 quarters. The position peaked at $37K in Q2 2013. 49 funds tracked by Wall St. Rank hold FRTX as of Q3 2015.

Joel Isaacson & Co reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
Joel Isaacson & Co sold 4 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $8K.
Joel Isaacson & Co first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 9 quarters.
Joel Isaacson & Co's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $37K in Q2 2013.
49 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Joel Isaacson & Co's 13F filing for Q3 2015, filed 21 Oct 2015.